The GMRF Clinical Trials Unit is currently recruiting for the following clinical trials in lung cancer:

PROTOCOL: CA001-050 (PI: DR KEN O’BYRNE)

Protocol Title: A Randomized, Open-label Phase 2 Clinical Trial of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

Lay Title: A Study of BMS-986012 in Combination With Carboplatin, Etoposide,  and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

Click here for more information